Xeris Biopharma CFO Steven Pieper disposes of 5,000 shares worth $42,500

PUBT · 19h ago
Xeris Biopharma CFO Steven Pieper disposes of 5,000 shares worth $42,500
  • Xeris Biopharma CFO Steven Pieper sold 5,000 common shares on Sep. 1, 2026 at USD 8.5.
  • Direct holdings fell to 1,356,053 shares following the sale.
  • Trade executed under a Rule 10b5-1 plan adopted on Aug. 18, 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001875714-26-000012), on September 01, 2026, and is solely responsible for the information contained therein.